Positron-emitting N-[18F]fluoroalkyl and [18F]fluoropyrrolidinyl analogues of eticlopride as potential in vivo radioligands for dopamine D2 receptors.

N-Fluoroalkyl and 4-fluoropyrrolidinyl eticlopride analogues with high affinity toward central nervous system dopamine D2 receptors in vitro were labelled with positron emitting fluorine-18 (t1/2 = 110 min), and their in vivo biodistribution was investigated in rats. N-[18F]Fluoro-ethyl and -propyl eticlopride derivatives showed poor in vivo selectivity in the rat brain. On the other hand, 4-[18F]fluoropyrrolidinyl eticlopride exhibited almost constant and relatively high striatal concentration. The striatal/cerebellar radioactivity ratio, which corresponds to the ratio of a brain D2 receptor-rich to poor region, gradually increased to 5.2-6.4, 90 min after the injection. The striatal accumulation was selectively inhibited by pre-injection of haloperidol, a dopamine D2 antagonist, without affecting accumulation in other tissues. Thus, the selective striatal accumulation of 4-[18F]fluoropyrrolidinyl eticlopride in striatal tissue appears to be due to the specific binding to dopamine D2 receptors.     

A novel approach to the synthesis of [18F]flumazenil,a radioligand for PET imaging of central benzodiazepine receptors

Russian Chemical Bulletin - An express method of solid-phase extraction was proposed for the first time for isolation and purification of [18F]flumazenil, a radioligand used to quantify the density...     

Clinical Relevance of [18F]Florbetaben and [18F]FDG PET/CT Imaging on the Management of Patients with Dementia

PET of β-Amyloid plaques (Aβ) using [¹⁸F]florbetaben ([¹⁸F]FBB) and [¹⁸F]fluorodeoxyglucose ([¹⁸F]FDG) increasingly aid clinicians in early diagnosis of dementia, including Alzheimer’s disease (AD), frontotemporal disease, dementia with Lewy bodies, and vascular dementia. The aim of this retrospective analysis was to evaluate clinical relevance of [¹⁸F]FBB, [¹⁸F]FDG PET and complimentary CSF measurements in patients with suspected dementia. In this study, 40 patients with clinically suspected or history of dementia underwent (1) measurement of Aβ peptides, total tau, and p-tau protein levels in the cerebrospinal fluid (CSF) compared with healthy controls (HC); (2) clinical and neuropsychological assessment, which included Consortium to Establish a Registry for Alzheimer’s Disease neuropsychological assessment battery (CERAD-NAB); (3) [¹⁸F]FBB and [¹⁸F]FDG PET imaging within an average of 3 weeks. The subjects were within 15 days stratified using PET, CSF measurements as HC, mild cognitive impaired (MCI) and dementia including Alzheimer´s disease. The predictive dementia-related cognitive decline values were supporting the measurements. PET images were evaluated visually and quantitatively using standard uptake value ratios (SUVR). Twenty-one (52.5%) subjects were amyloid-positive (Aβ+), with a median neocortical SUVR of 1.80 for AD versus 1.20 relative to the respective 19 (47.5 %) amyloid-negative (Aβ-) subjects. Moreover, the [¹⁸F]FDG and [¹⁸F]FBB confirmed within a sub-group of 10 patients a good complimentary role by correlation between amyloid pathology and brain glucose metabolism in 8 out of 10 subjects. The results suggest the clinical relevance for [¹⁸F]FBB combined with [¹⁸F]FDG PET retention and CFS measurements serving the management of our patients with dementia. Therefore, [¹⁸F]FBB combined with [¹⁸F]FDG PET is a helpful tool for differential diagnosis, and supports the patients’ management as well as treatment.     

QM/MM modeling of compound I active species in cytochrome P450, cytochrome C peroxidase, and ascorbate peroxidase

QM/MM calculations provide a means for predicting the electronic structure of the metal center in metalloproteins. Two heme peroxidases, Cytochrome c Peroxidase (CcP) and Ascorbate Peroxidase (APX), have a structurally very similar active site, yet have active intermediates with very different electronic structures. We review our recent QM/MM calculations on these systems, and present new computational data. Our results are in good agreement with experiment, and suggest that the difference in electronic structure is due to a large number of small differences in structure from one protein to another. We also discuss recent QM/MM calculations on the active species of cytochrome P450, in which a similar sensitivity of the electronic structure to the environment is found. However, this does not appear to explain different catalytic profiles of the different drug-metabolizing isoforms of this class of enzyme.     

Yield ratio of [11C]-CO2, [11C]-CO and [11C]-CH4 from the irradiation of N2/H2-mixtures in a gas target

The¹⁴N/p, /¹¹C-reaction was studied in different N₂/H₂-mixtures. The products are [¹¹C]-CO₂, [¹¹C]-CO and [¹¹C]-CH₄. The yield ratio may be controlled by varying the bombardment conditions. High pressure, high H₂-content, high beam current and high proton energy shift the ratio towards [¹¹C]-CH₄. Lower beam current and lower proton energy increase the yield of [¹¹C]-CO₂. The production of [¹¹C]-CO is constant over a wide range of conditions /about 10%/. For the production of [¹¹C]-CH₄ in good yield a target gas holder for high pressures has been developed. Details are given in Fig. 7. This target gas holder was filled with 5% H₂ in N₂ at 3×10⁶ Pa. Proton irradiation of the mixture gives a typical yield of [¹¹C]-CH₄ of 400–500 mCi at a beam current of 15–20 A within 20 min. Only traces of other¹¹C-labelled compounds could be detected under these conditions.     

1-[18F]Fluoroethyleneglycol-2-nitroimidazoles, a new class of potential hypoxia PET markers

Summary 1-[2-(2-Fluoroethoxy)ethyl]-2-1H-nitroimidazole (3a), 1-{2-[2-(2-fluoroethoxy)ethoxy]ethyl}-2-1H-nitroimidazole (3b) and 1-(2-{2-[2-(2-fluoroethoxy)ethoxy]ethoxy}ethyl)-2-1H-nitroimidazole (3c) were synthesized in a two step sequence.Coupling the ditosylate of di-, tri- or tetraethylene glycol with 2-nitroimidazole followed by fluoride substitution afforded the reference compounds in high yield and¹⁸F labeling gave the corresponding markers in 70-82% radiochemical yield.     

Preparation, characterization, and substrate metabolism of gold-immobilized cytochrome P450 2C9

The cytochrome P450 enzymes represent an important class of heme-containing enzymes. There is considerable interest in immobilizing these enzymes on a surface so that interactions between a single enzyme and other species can be studied with respect to electron transfer, homodimer or heterodimer interactions, or for construction of biological-based chips for standardizing cytochrome P450 metabolism or for high-throughput screening of pharmaceutical agents. Previous studies have generally immobilized P450 enzymes in a matrix or on a surface. Here, we have attached CYP2C9 to gold substrates such that the resulting construct maintains the ability to bind and metabolize substrates in the presence of NADPH and cytochrome P450 reductase. The activity of these chips is directly dependent upon the linkers used to attach CYP2C9 and to the presence of key molecules in the active site during enzyme attachment. A novel method to detect substrate-enzyme binding, namely, superconducting quantum interference device (SQUID) magnetometry, was used to monitor the binding of substrates. Most significantly, conditions that allow measurable CYP2C9 metabolism to occur have been developed.     

Analysis of Pros and Cons in Using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007: Production,Costs, and PET/CT Applications in Patients with Prostate Cancer

The aim of this work is to compare [⁶⁸Ga]Ga-PSMA-11 and [¹⁸F]PSMA-1007 PET/CT as imaging agents in patients with prostate cancer (PCa). Comparisons were made by evaluating times and costs of the radiolabeling process, imaging features including pharmacokinetics, and impact on patient management. The analysis of advantages and drawbacks of both radioligands might help to make a better choice based on firm data. For [⁶⁸Ga]Ga-PSMA-11, the radiochemical yield (RCY) using a low starting activity (L, average activity of 596.55 ± 37.97 MBq) was of 80.98 ± 0.05%, while using a high one (H, average activity of 1436.27 ± 68.68 MBq), the RCY was 71.48 ± 0.04%. Thus, increased starting activities of [⁶⁸Ga]-chloride negatively influenced the RCY. A similar scenario occurred for [¹⁸F]PSMA-1007. The rate of detection of PCa lesions by Positron Emission Tomography/Computed Tomography (PET/CT) was similar for both radioligands, while their distribution in normal organs significantly differed. Furthermore, similar patterns of biodistribution were found among [¹⁸F]PSMA-1007, [⁶⁸Ga]Ga-PSMA-11, and [¹⁷⁷Lu]Lu-PSMA-617, the most used agent for RLT. Moreover, the analysis of economical aspects for each single batch of production corrected for the number of allowed PET/CT examinations suggested major advantages of [¹⁸F]PSMA-1007 compared with [⁶⁸Ga]Ga-PSMA-11. Data from this study should support the proper choice in the selection of the PSMA PET radioligand to use on the basis of the cases to study.     

阴离子开放骨架磷酸盐[A14P5O19(OH)][C6H18N2]和[Ga8P8PO32F5.5][C6H18N2]2[H30+]1.5水热合成中的对映体拆分

以外消旋的2-甲基-1,5-戊二胺(MPMD)为结构导向剂,在水热条件下合成出新磷酸铝化合物[Al4P5O19(OH)][C6H18N2](AlPO-MPMD)和新磷酸镓化合物[Ga8P8O32F5.5][C6H18N2]2[H30+]1.5(GaPO-MPMD).采用单晶x射线衍射结构分析、粉末x射线衍射分析(XRD)、热重-差热分析(TGA-DTA.A)、固体核磁共振(MAs NMR)、旋光分析(Optical rotation)以及振动圆二色光谱分析(Vibrational circular dichroism,VCD)等技术对产物进行了表征.对产物的VCD实验光谱和理论模拟光谱对比分析及旋光分析表明,在水热合成过程中,具有S构象的手性结构导向剂分子比具有R构象的手性结构导向剂分子更多地进入无机化合物骨架中,显示了手性对映体分子在该水热条件下的原位手性拆分.     

Asymmetric synthesis of L-2-amino[3-11C]butyric acid, L-[3-11C]norvaline and L-[3-11C]valine

The short-lived radionuclide 11C (t1/2 = 20.4 min) has been used in the asymmetric synthesis of L-2-amino[3-11C]butyric acid, L-[3-11C]-norvaline and L-[3-11C]valine. The syntheses were performed by alkylation of [(+)-2-hydroxypinanyl-3-idene]-glycine tert-butyl ester under anhydrous conditions in tetrahydrofuran/1,3-dimethyl-3,4,5,6-tetrahydro-2-pyrimidinone with lithiated 2,2,6,6-tetramethylpiperidine as base, using the appropriate 11C-alkyl iodides prepared in a one-pot reactor from [11C]carbon dioxide. Following removal of the protecting groups, the -[3-11C]amino acids were obtained in 80-82% enantiomeric excess and in 9-25% radiochemical yields, decay corrected and calculated on the basis of the amount of [11C]carbon dioxide at the start of the syntheses within 50-55 min.     

Preparation,Optimisation, and In Vitro Evaluation of [18F]AlF-NOTA-Pamidronic Acid for Bone Imaging PET

[¹⁸F]sodium fluoride ([¹⁸F]NaF) is recognised to be superior to [⁹⁹mTc]-methyl diphosphate ([^99mTc]Tc-MDP) and 2-deoxy-2-[¹⁸F]fluoro-D-glucose ([¹⁸F]FDG) in bone imaging. However, there is concern that [¹⁸F]NaF uptake is not cancer-specific, leading to a higher number of false-positive interpretations. Therefore, in this work, [¹⁸F]AlF-NOTA-pamidronic acid was prepared, optimised, and tested for its in vitro uptake. NOTA-pamidronic acid was prepared by an N-Hydroxysuccinimide (NHS) ester strategy and validated by liquid chromatography-mass spectrometry analysis (LC-MS/MS). Radiolabeling of [¹⁸F]AlF-NOTA-pamidronic acid was optimised, and it was ensured that all quality control analysis requirements for the radiopharmaceuticals were met prior to the in vitro cell uptake studies. NOTA-pamidronic acid was successfully prepared and radiolabeled with ¹⁸F. The radiolabel was prepared in a 1:1 molar ratio of aluminium chloride (AlCl₃) to NOTA-pamidronic acid and heated at 100 °C for 15 min in the presence of 50% ethanol (v/v), which proved to be optimal. The preliminary in vitro results of the binding of the hydroxyapatite showed that [¹⁸F]AlF-NOTA-pamidronic acid was as sensitive as [¹⁸F]sodium fluoride ([¹⁸F]NaF). Normal human osteoblast cell lines (hFOB 1.19) and human osteosarcoma cell lines (Saos-2) were used for the in vitro cellular uptake studies. It was found that [¹⁸F]NaF was higher in both cell lines, but [¹⁸F]AlF-NOTA-pamidronic acid showed promising cellular uptake in Saos-2. The preliminary results suggest that further preclinical studies of [¹⁸F]AlF-NOTA-pamidronic acid are needed before it is transferred to clinical research.     

A novel one-pot palladium-mediated synthesis of N-[(2-hydroxyphenyl)methyl]-N-(4-phenoxy-3-pyridinyl) acetamide, the precursor to [C]PBR28, a PET biomarker for the peripheral benzodiazepine receptor

Due to an urgent need to image the peripheral benzodiazepine receptor (PBR) in living human subjects using positron emission tomography imaging, we had cause to prepare N-[(2-hydroxyphenyl)methyl]-N-(4-phenoxy-3-pyridinyl) acetamide (desmethyl-PBR28 (1)), the precursor to [¹¹C]PBR28. Herein, we report a new synthesis of the precursor in which palladium-mediated reduction of the nitro pyridine to the corresponding amino pyridine, and subsequent reductive amination, can be achieved with decaborane in a convenient one-pot procedure. This procedure is operationally simpler than the current alternatives and provides high quality precursor suitable for use in clinical applications.     

The structure and energetics of triplet [B, C, F, H2]

In the current paper, we discuss our high level quantum chemical results for the structure and energetics of triplet (and hence open-shell) isomers corresponding to the stoichiometry of one boron, carbon, and fluorine apiece, and two hydrogens. While partially bond-ruptured excited ketene- and diazomethane-like H₂C-B-F and the carbene H(F)B-C-H plausibly emerge as the most stable isomers, a variety of novel structural features emerge for the assembled energy minima of at least 16 species. All of these species are compared as well as transition states that connect them. Comparison is made with corresponding forms of the singlet species with this stoichiometry, shown earlier by us to have a rich diversity of structures as well as a large range of energies and relative stabilities.     

Coordination compounds with the general formula trans-[M(18-crown-6)(C5HO2F6)2] as structural-thermochemical analogs. The complexes trans-[Pb(18-crown-6)(C5HO2F6)2] and trans-[Ba(18-crown-6)(C5HO2F6)2]

The molecular geometries of the complexes trans-[M(18-crown-6)(C₅HO₂F₆)₂] (where M = Ca, Sr, Ba (I), Zn, Cd, Sn, Pb (II), Fe, Co, Eu, and Yb) were modeled by the molecular mechanics method with fixed R(M-O) distances. The shielding degrees of the central metal atom in these complexes were calculated and the number and types of possible intermolecular contacts between their molecules in the structure were determined. The intermolecular interactions involve identical fragments (atoms) of the ligands: the CF₃ groups of the hexafluoroacetylacetonate ligands and the methylene fragments of the crown ether. Previously unknown complex II and complex I were synthesized according to an original procedure. The structure and thermochemical properties (including sublimation by the Knudsen method) of complex II were studied. As in complex I, the metal cation in complex II is in the cavity of the macrocycle of the crown ether; the hexafluoroacetylacetonate ligands are trans relative to that cation. The presumed similarity of complexes I and II in thermochemical characteristics was confirmed experimentally. Both the complexes melt in close temperature intervals and sublime at the same temperature (～10^?2 mm Hg) without decomposition. The enthalpies of sublimation of complexes I and II, as well as the entropy contributions to their volatilities, are equal to within the experimental error.     

A novel strategy for the preparation of the injectable PET/CT radiopharmaceutical (-)-[11C]-(1R,2S)-meta-hydroxyephedrine ((-)-[11C]HED

Positron emission tomography (PET) had been applied in clinical early diagnosis of various tumors and other diseases. The methylated synthetic conditions of (-)-[¹¹C]-(1R,2S)-meta-hydroxyephedrine ((-)-[¹¹C]HED), considered as one of the most important radiopharmaceuticals for PET, were optimized through single factor and orthogonal design methods. Here, we reported an improved purification protocol. The radiochemical yields of the final product were over 45% (decay-corrected and based on [¹¹C]methyl iodide) (n?=?50). The radiochemical purities and chemical purities were over 99% (n?=?50) and 97% (n?=?50), respectively. The automatic radiosynthesis procedure of (-)-[¹¹C]HED with relatively high radiochemical yield was convenient and reliable.

     

Stabilization of the P(CF3)(2)(-) and P(C6F5)(2)(-) ions by coordination to pentacarbonyl tungsten: structures of [18-crown-6-K]P(CF3)2, [18-crown-6-K][W[P(CF3)2](CO)5], and [18-crown-6-K][[W(CO)5]2[mu-P(C6F5)2]].THF

The stabilization of the P(CF(3))(2)(-) ion by intermediary coordination to the very weak Lewis acid acetone gives access to single crystals of [18-crown-6-K]P(CF(3))(2). The X-ray single crystal analysis exhibits nearly isolated P(CF(3))(2)(-) ions with an unusually short P-C distance of 184(1) pm, which can be explained by negative hyperconjugation and is also found by quantum chemical hybrid DFT calculation. Coordination of the P(CF(3))(2)(-) ion to pentacarbonyl tungsten has only a minor effect on electronic and geometric properties of the P(CF(3))(2) moiety, while a strong increase in thermal stability of the dissolved species is achieved. The hitherto unknown P(C(6)F(5))(2)(-) ion is stabilized by coordination to pentacarbonyl tungsten and isolated as a stable 18-crown-6 potassium salt, [18-crown-6-K][W[P(C(6)F(5))(2)](CO)(5)], which is fully characterized. The tungstate, [W[P(C(6)F(5))(2)](CO)(5)](-), decomposes slowly in solution, while coordination of the phosphorus atom to a second pentacarbonyl tungsten moiety results in an enhanced thermal stability in solution. The single-crystal X-ray analysis of [18-crown-6-K][[W(CO)(5)](2)[mu-P(C(6)F(5))(2)]].THF exhibits a very tight arrangement of the two C(6)F(5) and two W(CO)(5) groups around the central phosphorus atom. NMR spectroscopic investigations of the [[W(CO)(5)](2)[mu-P(C(6)F(5))(2)]](-) ion exhibit a hindered rotation of both the C(6)F(5) and W(CO)(5) groups in solution.